CEO Dr. Volker Gerdts says VIDO-InterVac is now focusing on comparing the results in hamsters after demonstrating the vaccine’s efficacy in ferrets.
Global News Morning Regina
VIDO-InterVac shifts focus to hamsters in efforts to create COVID-19 vaccine
More Videos
You are viewing an Accelerated Mobile Webpage.
View Original Article